Accès ouvert
2021
article
OpenAlex
Laura López‐Marín, Raymed A. Bacallao-Méndez, Betsy Llerena‐Ferrer, Aymara Badell-Moore et autres
INTRODUCTION: During the pandemic caused by the SARS-CoV-2 virus, some patients who develop severe forms of COVID-19 present thrombotic microangiopathy in the course of the disease's clinical progression. METHODS: Data came from direct patient observation and clinical records. We performed a kidney …
Accès ouvert
2021
article
OpenAlex
Laura López‐Marín, Carlos Orantes, Raúl Herrera-Valdés, Miguel Almaguer-López et autres
Introduction: Chronic kidney disease mainly affecting male farmers and not associated to traditional causes has been present in Central America for twenty years. The condition is characterized by the presence of chronic interstitial nephritis, but its ultrastructural features are not fully known. …
br, ar, cu, us, sv, es
(code pays fourni par la source)
2017
article
OpenAlex
Carlos Orantes, Raúl Herrera-Valdés, Miguel Almaguer-López, Laura López‐Marín et autres
us, sv, cu
(code pays fourni par la source)
2017
book-chapter
OpenAlex
Raúl Herrera-Valdés, Miguel Almaguer-López, José A. Chipi-Cabrera, Jorge F. Pérez-Oliva-Díaz
cu
(code pays fourni par la source)
2017
paratext
OpenAlex
Lawrence Y. Agodoa, Ejaz Ahmed, Fazal Akhtar, Luz Alcántar-Vallín et autres
us, pk, mx, cu, Cameroun, Égypte, ca, gb, nz, ar
(code pays fourni par la source)
Accès ouvert
2008
article
OpenAlex
Raúl Herrera-Valdés, Miguel Almaguer, J. Chipi, X. Toirac et autres
Introduction: Obesity is a social disease constituting a global pandemic. It is present in 90% of diabetic and 65% of hypertensive patients. It is associated with cardiometabolic syndrome and with damaging physiopathological mechanisms, particularly for the vascular system and the kidneys. On …
us
(code pays fourni par la source)
Accès ouvert
2005
article
OpenAlex
Raúl Herrera-Valdés, Miguel Almaguer-López
cu
(code pays fourni par la source)
Accès ouvert
2005
article
OpenAlex
Jorge F. Pérez-Oliva, Martha Casanova-González, Idrian García‐García, Pedro J Porrero-Martín et autres
BACKGROUND: Recombinant human erythropoietin (EPO) is used for the treatment of last stage renal anemia. A new EPO preparation was obtained in Cuba in order to make this treatment fully nationally available. The aim of this study was to compare the pharmacokinetic, …
cu
(code pays fourni par la source)